Trinity Biotech plc (TRIB)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Clinical Laboratory Goods	31.68M	39.37M	42.29M	46.04M	-
Clinical Laboratory Goods Growth	-19.54%	-6.90%	-8.14%	-	-
Clinical Laboratory Services	4.01M	4.75M	5.45M	7.27M	-
Clinical Laboratory Services Growth	-15.66%	-12.89%	-25.01%	-	-
Point-Of-Care Products	8.10M	17.43M	9.09M	9.21M	-
Point-Of-Care Products Growth	-53.53%	91.76%	-1.32%	-	-
Total	43.79M	61.56M	56.83M	62.52M	-
Total Growth	-28.87%	8.31%	-9.10%	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Americas	51.98M	61.61M	66.85M	76.62M	116.31M
Americas Growth	-15.63%	-7.84%	-12.75%	-34.12%	-15.10%
Rest of World – Ireland	15.00M	20.47M	12.72M	25.10M	28.23M
Rest of World – Ireland Growth	-26.70%	60.89%	-49.32%	-11.10%	11.21%
Eliminations	-23.19M	-20.52M	-22.74M	-26.94M	-51.58M
Total	43.79M	61.56M	56.83M	74.78M	92.97M
Total Growth	-28.87%	8.31%	-24.00%	-19.56%	-8.84%

Source: S&P Global Market Intelligence.